Literature DB >> 10380936

Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas.

R Kumar1, J Smeds, B Lundh Rozell, K Hemminki.   

Abstract

Loss of heterozygosity (LOH) was determined in 45 sporadic primary melanomas at six polymorphic microsatellite markers that flank the INK4a (p16-p14ARF) locus on chromosome 9p21. We also determined allelic loss at two markers on chromosome 9q and two markers at the Rb locus on chromosome 13. Homozygous deletion of the p16 and p14ARF genes was determined by a fluorescent-based quantitative multiplex polymerase chain reaction method. LOH at one or more polymorphic microsatellite markers on locus 9p21 was found in 32 of the melanomas (71%). The highest proportion of LOH was found at markers D9S736 and D9S104, which are telomeric and centromeric to the INK4 locus, respectively. Five melanomas showed LOH at all the analysed markers located on chromosome 9p21. LOH at markers D9S942 and D9S974, which are located close to the p16 and p14ARF genes, was found in 39% and 46% of melanomas, respectively. Analysis of the marker D9S257 on 9q22.1 showed LOH in 13 melanomas (44% of the informative cases). A subset of melanomas with LOH at the INK4 locus also carried inactivating mutations within the p16 coding sequence. Four melanomas carried homozygous deletions at the p16-p14ARF locus. Our results suggest, besides the involvement of the INK4 locus in sporadic melanomas, the possibility of the existence of additional tumour suppressor loci on chromosome 9.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380936     DOI: 10.1097/00008390-199904000-00005

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  10 in total

1.  Increased C-MYC copy numbers on the background of CDKN2A loss is associated with improved survival in nodular melanoma.

Authors:  Denitsa Koynova; Ekaterina Jordanova; Nicole Kukutsch; Pieter van der Velden; Draga Toncheva; Nelleke Gruis
Journal:  J Cancer Res Clin Oncol       Date:  2006-09-15       Impact factor: 4.553

2.  Expression, deletion [was deleton] and mutation of p16 gene in human gastric cancer.

Authors:  X S He; Q Su; Z C Chen; X T He; Z F Long; H Ling; L R Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.

Authors:  D P O'Connor; E W Kay; M Leader; G M Murphy; G J Atkins; M J Mabruk
Journal:  Mol Pathol       Date:  2001-06

Review 4.  Melanoma genetics and the development of rational therapeutics.

Authors:  Yakov Chudnovsky; Paul A Khavari; Amy E Adams
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

5.  Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example.

Authors:  Kari Hemminki; Aayushi Srivastava; Sivaramakrishna Rachakonda; Obul Bandapalli; Eduardo Nagore; Akseli Hemminki; Rajiv Kumar
Journal:  Hered Cancer Clin Pract       Date:  2020-07-31       Impact factor: 2.857

6.  Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase.

Authors:  Oddbjørn Straume; Johanna Smeds; Rajiv Kumar; Kari Hemminki; Lars Andreas Akslen
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

7.  Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma.

Authors:  Joan A Puig-Butillé; Celia Badenas; Zighereda Ogbah; Cristina Carrera; Paula Aguilera; Josep Malvehy; Susana Puig
Journal:  Exp Dermatol       Date:  2013-02       Impact factor: 3.960

Review 8.  Associations between environmental factors and incidence of cutaneous melanoma. Review.

Authors:  Katarina Volkovova; Dagmar Bilanicova; Alena Bartonova; Silvia Letašiová; Maria Dusinska
Journal:  Environ Health       Date:  2012-06-28       Impact factor: 5.984

9.  Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group.

Authors:  G Palmieri; A Cossu; P A Ascierto; G Botti; M Strazzullo; A Lissia; M Colombino; M Casula; C Floris; F Tanda; M Pirastu; G Castello
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.

Authors:  Hui Deng; Jing Liu; Yu Deng; Gangwen Han; Yiqun G Shellman; Steven E Robinson; John J Tentler; William A Robinson; David A Norris; Xiao-Jing Wang; Qinghong Zhang
Journal:  J Invest Dermatol       Date:  2013-01-10       Impact factor: 8.551

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.